The GOALPOST Trial builds on the findings of CHAP and Sinkey’s preliminary clinical trial, called the ACHIEVE Trial, which is ...

Biomed Industries, Inc. Unveils a New Neurogenesis Hypothesis with Clinical Data of NA-831 for Alzheimer's and NA-901 for Major Depressive Disorder Treatment Neurogenesis Hypothesis offers a promising ...

The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...

More than two years after the FDA held a public workshop on measuring overall survival (OS) in clinical cancer trials, the agency has released a draft guidance on the topic, recommending that OS be ...

Google’s C2S-Scale 27B foundation model, developed in partnership with Yale University and based on the Gemma framework, has predicted a new hypothesis of cance ...

The THIO-101 patient with 30-month survival received therapy every three weeks, and concluded treatment upon reaching the maximum treatment duration of 2 years based on protocol requirements. MAIA’s ...